Baid Finserv Q1FY27: PAT +8% YoY on lending growth as credit costs triple
PAT +8.17% YoY · revenue -8.98% · margins expanding
₹21.65 Cr
-8.98% YoY
₹4.34 Cr
+8.17% YoY
19.7%
+2.9pp YoY
₹0.28
Baid Finserv's standalone net profit rose 8.2% YoY to Rs.4.34 Cr (from Rs.4.02 Cr in Q1 FY26) on a PBT of Rs.5.81 Cr, even as headline revenue from operations dipped 8.98% YoY to Rs.21.65 Cr. The revenue decline is an optical effect rather than a lending slowdown: core interest income — over 99% of this quarter's revenue — grew 13.1% YoY to Rs.21.55 Cr, while a non-core 'Sale of Products' trading line that contributed Rs.4.30 Cr in the year-ago quarter fell to nil this quarter; the matching cost of that trading book (booked through inventory changes) also reversed, so the net profit impact of its disappearance was negligible.
Q1 FY-2027 vs prior quarters
The profit growth came despite impairment/credit-cost provisioning nearly tripling YoY to Rs.2.85 Cr (from Rs.0.86 Cr) — the main line to watch for asset-quality drift — which was more than offset by the interest-income growth and the absence of low-margin trading COGS. Sequentially, PAT surged 162% QoQ from Rs.1.66 Cr, but that flatters the quarter: Q4 FY26 carried an unusually heavy Rs.5.41 Cr impairment charge, so the QoQ jump is a base-effect normalization in provisioning rather than a step-change in the core business, which itself grew a more modest 6.1% QoQ on interest income. Net profit margin (PAT/total income) expanded to 19.7% from 16.8% YoY and from 6.5% in Q4.
The stock went into the print at ₹10, down 3% over the past month of trading.
EPS came in at Rs.0.28 (basic), down 16.4% YoY from Rs.0.33, despite the profit growth — paid-up equity capital rose to Rs.30.98 Cr from Rs.24.01 Cr a year ago (~29% more shares outstanding), so the per-share metric absorbed a dilution the aggregate profit figure doesn't show. We found no analyst previews or consensus estimates for this stock — a micro-cap with essentially no sell-side coverage — and neither our records nor the filing carry any formal prior guidance, so both the vs-street and vs-guidance verdicts are unknown rather than a beat or miss. No management press release or concall commentary accompanied this filing to cross-check against.
W1
Impairment/credit-cost trend — Rs.2.85 Cr this quarter (3x YoY, though down from Rs.5.41 Cr in Q4 FY26); watch whether it keeps rising or reverts toward the ~Rs.0.86-1.0 Cr run-rate
W2
Co-lending scale-up — only 2 CLAs live with Rs.20.10 Cr outstanding as of Jun 30, 2026; watch growth now that RBI's Nov 2025 co-lending framework is in effect (from Jan 1, 2026)
W3
EPS dilution drag — equity base up ~29% YoY (Rs.30.98 Cr vs Rs.24.01 Cr paid-up capital); watch whether profit growth outpaces further share-count increases